VDC
ATRC icon

Van Diest Capital’s AtriCure ATRC Stock Holding History

Van Diest Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$263K Buy
+9,386
New +$264K 0.24% 138

Other funds holding ATRC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Van Diest Capital's ATRC Position: Q2 2026 in Review

Van Diest Capital opened a new position in AtriCure (ATRC) in Q2 2026: 9,386 shares worth $263K. The stake represents 0.24% of the portfolio and ranks #138 among its holdings.

252 funds tracked by Wall St. Rank hold ATRC as of Q2 2026.

  • Van Diest Capital held 9,386 shares of AtriCure worth $263K as of Q2 2026.
  • AtriCure was a new Van Diest Capital position in Q2 2026.
  • AtriCure made up 0.24% of Van Diest Capital's portfolio in Q2 2026, its #138 holding.
  • 252 funds tracked by Wall St. Rank held AtriCure as of Q2 2026.

Based on Van Diest Capital's 13F filing for Q2 2026, filed 4 Aug 2026.